LLS Urges Blood Cancer Patients to get Vaccinated as its National Patient Registry Enters Next Phase in COVID-19 Vaccine StudiesPosted On: July 15, 2021
Rye Brook, N.Y., July 15, 2021—The Leukemia & Lymphoma Society® (LLS) began recruitment this week for a new study evaluating T-cell immune response to COVID-19 vaccine among people with a current or past diagnosis of blood cancer. This invitation-only follow-up study will include a sub-set of participants from a larger LLS study examining COVID-19 spike antibody response to vaccination. Read More
WASHINGTON, D.C, June 17, 2021 – 34 patient organizations representing millions of people living with serious and chronic health conditions issued the following statement regarding the Supreme Court’s ruling upholding the Affordable Care Act:Read More
The Leukemia & Lymphoma Society launches Impact Research grants to help underserved patients access to clinical trialsPosted On: May 6, 2021
Collaborations with Mayo Clinic, Vanderbilt University Medical Center and Weill Cornell Medicine will Increase Representation of Geographically, Ethnically and Economically Underserved Communities in Clinical Trials.Read More
Please send all media-related inquiries and interview requests to email@example.com. An LLS representative will respond as soon as possible.